| Title |
Hematopoietic stem cell transplantation for Gaucher disease.
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2012
|
| DOI | 10.1002/14651858.cd006974.pub3 |
| Pubmed ID | |
| Authors |
Somaraju UR, Tadepalli K |
| Abstract |
Gaucher disease is the most common lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase. Current treatment of the disease involves a choice among enzyme replacement therapy, substrate reduction therapy and stem cell transplantation. Stem cell transplantation is a high risk procedure with possible long-term benefits in the regression of skeletal and neurological changes in people with Gaucher disease. |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 25 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 28% |
| Researcher | 5 | 20% |
| Student > Postgraduate | 4 | 16% |
| Student > Master | 4 | 16% |
| Student > Ph. D. Student | 3 | 12% |
| Other | 1 | 4% |
| Unknown | 1 | 4% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 48% |
| Biochemistry, Genetics and Molecular Biology | 2 | 8% |
| Nursing and Health Professions | 2 | 8% |
| Mathematics | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 4 | 16% |
| Unknown | 3 | 12% |